Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NYSE:BIOA

(BIOA) (BIOA) Stock Price, News & Analysis

(BIOA) logo

About (BIOA) Stock (NYSE:BIOA)

Advanced Chart

Key Stats

Today's Range
$4.40
$5.00
50-Day Range
N/A
52-Week Range
$2.88
$26.62
Volume
512,188 shs
Average Volume
465,768 shs
Market Capitalization
$150.39 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$5.67
Consensus Rating
Reduce

Company Overview

Receive BIOA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for (BIOA) and its competitors with MarketBeat's FREE daily newsletter.

BIOA Stock News Headlines

Bioage Labs Inc BIOA
How to Collect Up To $5,917/mo From Trump’s Made In USA Boom
How to Collect Up To $5,917/mo From Trump's Made In USA Boom Thanks to President Trump's America-First policies, a historic wave of investment is flooding back into the United States: Apple committing a colossal $500 billion to build new U.S. factories. Microsoft injecting $80 billion into domestic manufacturing. Nvidia moving critical chip production back to America. But here's the hidden opportunity: There's now a groundbreaking way for you to start collecting monthly checks from these very same companies— checks that could reach as high as $5,917 each month. Don't miss your chance to participate directly in America's industrial comeback.
BioAge Labs, Inc. Common Stock (BIOA)
BioAge Labs completes IND-enabling studies for BGE-102
See More Headlines

BIOA Stock Analysis - Frequently Asked Questions

(BIOA) (NYSE:BIOA) released its quarterly earnings results on Thursday, November, 7th. The biotechnology company reported ($6.70) earnings per share for the quarter, missing analysts' consensus estimates of ($0.62) by $6.08.

(BIOA) (BIOA) raised $198 million in an initial public offering (IPO) on Thursday, September 26th 2024. The company issued 11,000,000 shares at $18.00 per share.

Based on aggregate information from My MarketBeat watchlists, some other companies that (BIOA) investors own include ProQR Therapeutics (PRQR), Flexion Therapeutics (FLXN), Rite Aid (RAD), LadRx (CYTR), Intellipharmaceutics International (IPCIF), NVIDIA (NVDA) and AbbVie (ABBV).

Company Calendar

Last Earnings
11/07/2024
Today
7/03/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NYSE
Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
N/A
Current Symbol
NYSE:BIOA
Fax
N/A
Employees
N/A
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$5.67
High Stock Price Target
$7.00
Low Stock Price Target
$5.00
Potential Upside/Downside
+35.1%
Consensus Rating
Reduce
Rating Score (0-4)
1.75
Research Coverage
4 Analysts

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Price / Cash Flow
N/A
Price / Book
N/A

Miscellaneous

Free Float
N/A
Market Cap
$150.39 million
Optionable
Not Optionable
Beta
N/A
10 Stocks Set to Soar in Summer 2025 Cover

Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Summer 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.

Get This Free Report

This page (NYSE:BIOA) was last updated on 7/3/2025 by MarketBeat.com Staff
From Our Partners